clinicalev

75 results found.

Top Stocks matching your search for "clinical ev"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
NIO

NIO Inc - ADR

-15.11%

$10.92 - $9.27

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 13, 2023

$NIO ALL MARKETS BRIGHT GREEN AND ENTERING BULL MARKET PHASE.

Jan, 11, 2023

Nio very undervalued, exponential grown not even hit phase 1 🌤👍

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
RIDE

Lordstown Motors Corp.

-45.04%

$1.38 - $0.76

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 8, 2022

Clinical stages and jumps 286% up to $9.76 from $1.77.

Dec, 3, 2022

The market learned excellent news about NWBO: its ... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
THMO

ThermoGenesis Holdings Inc

-2.35%

$3.83 - $3.74

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

By utilizing a specialized database, this study is... See more

Mar, 16, 2023

By utilizing a specialized database, this study is... See more

NIO

NIO Inc - ADR

-15.11%

$10.92 - $9.27

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 13, 2023

$NIO ALL MARKETS BRIGHT GREEN AND ENTERING BULL MARKET PHASE.

Jan, 11, 2023

Nio very undervalued, exponential grown not even hit phase 1 🌤👍

Nov, 22, 2022

We are now entering growth phase again.

Nov, 2, 2022

They will change how AML Is treated, there phase 3 trials wre a home run.

Oct, 31, 2022

Hyper growth phase underway.

Oct, 26, 2022

$NIO NIO is smack in the middle of entering it's highest growth phase since inception.

Oct, 7, 2022

It is a great way for consumers to trial the car before buying it.

RIDE

Lordstown Motors Corp.

-45.04%

$1.38 - $0.76

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 8, 2022

Clinical stages and jumps 286% up to $9.76 from $1.77.

Dec, 3, 2022

The market learned excellent news about NWBO: its key drug had met both its primary and secondary endpoints in its GBM clinical trial with excellent news that should have caused NWBO’s share price to increase, absent manipulation in the market.

Oct, 31, 2022

$RIDE wow this consolidaiton phase is massive.

Oct, 24, 2022

Its great we are in production phase of the endurance to FLEETs,

THMO

ThermoGenesis Holdings Inc

-2.35%

$3.83 - $3.74

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

By utilizing a specialized database, this study is ensuring the utmost safety and efficacy of the medication.

Mar, 16, 2023

By utilizing a specialized database, this study is ensuring the utmost safety and efficacy of the medication.

Mar, 16, 2023

Exciting news from ENSC🚀 The company has made significant progress in their human abuse potential study of PF614, a pain medication.